SPIRIT Small Vessel Registry

Stopped early · Not applicable

Conditions studied: Coronary Artery Disease, Atherosclerosis, Myocardial Ischemia

In brief

To evaluate the safety and effectiveness of the 2.25 mm XIENCE V® Everolimus Eluting Coronary Stent System (XIENCE V® EECSS) in improving coronary luminal diameter in subjects with ischemic heart disease due to a maximum of two de novo native coronary artery lesions in small vessels, each in a different epicardial vessel.

Key facts

Study ID
NCT00783796
Run by
Abbott Medical Devices
People needed
150
Starts
2008-10-01
Expected to finish
2013-12-01
Last updated by the study team
2019-05-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.